This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor “Possible Dose-Response Relationship for Risperidone in Obsessive-Compulsive Disorder”

Dan J. Stein, Susan Hawkridge, Colin Bouwer, and Robin A. Emsley

Published: March 15, 1998

Article Abstract

Sir: We appreciate the thoughtful observations of Dr. Baker. It seems clear, as we concluded in our paper, that there is a need for further controlled research to confirm the positive findings so far achieved in open trials of risperidone augmentation of serotonin reuptake inhibitors (SRIs) in obsessive-compulsive disorder (OCD) and to obtain information about optimal dosage and duration of risperidone.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Obsessive-Compulsive and Related Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...